Sponsored by Lonza 18 Nov 2025 On the fast track to the clinic: early decisions in drug development As biologics grow more complex, Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that cut risk and speed development. November 18, 2025 - 7 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 9 Sep 2025 Advanced expression vector design to overcome challenges in developing multichain biotherapeutics Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems. September 9, 2025 - 8 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
Podcast 5 Sep 2025Navigating the biotech development journey from first steps to global scale with Lonza Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies. September 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Lonza 10 Sep 2024 Accelerating the path to clinical filing applications with rapid toxicology material delivery Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials. September 10, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 3 Sep 2024 The crucial role of GS-CHO innovation in biopharmaceutical progress Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins. September 3, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 26 Mar 2024 Large molecule manufacturing: addressing challenges with strategies for success Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success. March 26, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 16 Jan 2024 Mastering biologics tech transfer: key success factors Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors. January 16, 2024 - 8 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2023 Lonza boosts ADC portfolio with Synaffix acquisition Lonza has acquired Synaffix B.V., a biotech company focused on commercializing its clinical-stage technology platform for the development of antibody drug conjugates (ADCs). While ADCs offer widespread and targeted treatment potential against cancer, they present a range of complex development and manufacturing challenges. Supported by a team of scientific experts, the Synaffix technology platform, which […] June 1, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2022 Lonza and Touchlight collaboration will expands customer’s access to DNA Manufacturing partner, Lonza, has today (September 6) announced a collaboration with Touchlight, a biotech company that works with enzymatic DNA production enabling genetic medicine. Through this collaboration, Lonza says it will have the ability to expand it end-to-end offering for mRNA manufacturing with an additional source of DNA raw material. This material comes from Touchlight’s […] September 6, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 31 Aug 2022 How CDMOs keep pace with trends in advanced therapies Advanced therapies including cell and gene therapies are exploding in demand, but the manufacturing process can be difficult. Jean-Christophe Hyvert, president of biologics and cell & gene at the CDMO Lonza, sheds light on the latest trends in advanced therapies and how manufacturers are keeping up. In 2021, global funding going to cell and gene […] August 31, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email